196 related articles for article (PubMed ID: 33394027)
1. Heteromeric complex formation between human cytochrome P450 CYP1A1 and heme oxygenase-1.
Connick JP; Reed JR; Cawley GF; Backes WL
Biochem J; 2021 Jan; 478(2):377-388. PubMed ID: 33394027
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: Interactions between CYP1A2 and heme oxygenase-1.
Connick JP; Reed JR; Cawley GF; Backes WL
J Biol Chem; 2021; 296():100030. PubMed ID: 33148696
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Interactions Among CYP1A2, CYP2B4, and NADPH-cytochrome P450 Reductase: Identification of Specific Protein Complexes.
Connick JP; Reed JR; Backes WL
Drug Metab Dispos; 2018 Mar; 46(3):197-203. PubMed ID: 29233819
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of CYP1 enzymes: Complex formation, membrane localization and function.
Connick JP; Reed JR; Cawley GF; Saha A; Backes WL
J Inorg Biochem; 2023 Oct; 247():112325. PubMed ID: 37479567
[TBL] [Abstract][Full Text] [Related]
5. Effect of homomeric P450-P450 complexes on P450 function.
Reed JR; Connick JP; Cheng D; Cawley GF; Backes WL
Biochem J; 2012 Sep; 446(3):489-97. PubMed ID: 22738171
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of heme oxygenase-1 partially reverses the arsenite-mediated decrease of CYP1A1, CYP1A2, CYP3A23, and CYP3A2 catalytic activity in isolated rat hepatocytes.
Anwar-Mohamed A; Klotz LO; El-Kadi AO
Drug Metab Dispos; 2012 Mar; 40(3):504-14. PubMed ID: 22159698
[TBL] [Abstract][Full Text] [Related]
7. Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase.
Pandey AV; Flück CE; Mullis PE
Biochem Biophys Res Commun; 2010 Sep; 400(3):374-8. PubMed ID: 20732302
[TBL] [Abstract][Full Text] [Related]
8. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
Marohnic CC; Huber Iii WJ; Patrick Connick J; Reed JR; McCammon K; Panda SP; Martásek P; Backes WL; Masters BS
Arch Biochem Biophys; 2011 Sep; 513(1):42-50. PubMed ID: 21741353
[TBL] [Abstract][Full Text] [Related]
9. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
Backes WL; Batie CJ; Cawley GF
Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
[TBL] [Abstract][Full Text] [Related]
10. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
Chou YT; Hsu FF; Hu DY; Chen YC; Hsu YH; Hsu JT; Chau LY
J Biomed Sci; 2018 Jan; 25(1):6. PubMed ID: 29361943
[TBL] [Abstract][Full Text] [Related]
11. Posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by methylmercury in HepG2 cells: a role of heme oxygenase-1.
Amara IE; Anwar-Mohamed A; El-Kadi AO
Toxicol Lett; 2013 Jun; 219(3):239-47. PubMed ID: 23541843
[TBL] [Abstract][Full Text] [Related]
12. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
14. Arsenite down-regulates cytochrome P450 1A1 at the transcriptional and posttranslational levels in human HepG2 cells.
Anwar-Mohamed A; El-Kadi AO
Free Radic Biol Med; 2010 May; 48(10):1399-409. PubMed ID: 20188822
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
[TBL] [Abstract][Full Text] [Related]
16. Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO-1) expression and modulation of delta-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats.
Iba MM; Alam J; Touchard C; Thomas PE; Ghosal A; Fung J
Biochem Pharmacol; 1999 Aug; 58(4):723-34. PubMed ID: 10413312
[TBL] [Abstract][Full Text] [Related]
17. Identification of the contact region responsible for the formation of the homomeric CYP1A2•CYP1A2 complex.
Saha A; Connick JP; Reed JR; Lott CS; Backes WL
Biochem J; 2021 Jun; 478(11):2163-2178. PubMed ID: 34032264
[TBL] [Abstract][Full Text] [Related]
18. C-Terminal membrane spanning region of human heme oxygenase-1 mediates a time-dependent complex formation with cytochrome P450 reductase.
Huber Iii WJ; Scruggs BA; Backes WL
Biochemistry; 2009 Jan; 48(1):190-7. PubMed ID: 19123922
[TBL] [Abstract][Full Text] [Related]
19. MG-132 inhibits the TCDD-mediated induction of Cyp1a1 at the catalytic activity but not the mRNA or protein levels in Hepa 1c1c7 cells.
Anwar-Mohamed A; Elbekai RH; El-Kadi AO
Toxicol Lett; 2008 Nov; 182(1-3):121-6. PubMed ID: 18835339
[TBL] [Abstract][Full Text] [Related]
20. The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions.
Park JW; Reed JR; Backes WL
J Biol Chem; 2015 Dec; 290(49):29449-60. PubMed ID: 26468279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
